Literature DB >> 231072

Lack of susceptibility of marmosets to human non-A, non-B hepatitis.

E Tabor, L B Seeff, R J Gerety.   

Abstract

Infectious sera from three humans with chronic non-A, non-B hepatitis, whose blood or serum had transmitted non-A, non-B hepatitis both to other humans and to experimentally inoculated chimpanzees, were inoculated into five marmosets. A sixth uninoculated marmoset served as a control. No elevations in levels of serum alanine aminotransferase or isocitric dehydrogenase occurred in serum samples obtained weekly from any of the marmosets during three months following inoculation. This study indicates that certain species of marmoset, which are susceptible to and provide well-documented animal models for hepatitis A and GB-agent hepatitis, do not appear to be susceptible to the agent(s) of human non-A, non-B hepatitis. In addition, this study suggests that the agent(s) of human non-A, non-B hepatitis and the GB agent are probably different.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 231072     DOI: 10.1093/infdis/140.5.794

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Identification of two flavivirus-like genomes in the GB hepatitis agent.

Authors:  J N Simons; T J Pilot-Matias; T P Leary; G J Dawson; S M Desai; G G Schlauder; A S Muerhoff; J C Erker; S L Buijk; M L Chalmers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

2.  Interactions Between GB Virus Type C and HIV.

Authors:  Sarah L. George; Sabina Wünschmann; James McCoy; Jinhua Xiang; Jack T. Stapleton
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.663

Review 3.  The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae.

Authors:  Jack T Stapleton; Steven Foung; A Scott Muerhoff; Jens Bukh; Peter Simmonds
Journal:  J Gen Virol       Date:  2010-11-17       Impact factor: 3.891

Review 4.  Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections.

Authors:  Rohan Janardhan Meshram; Gunderao Hanumantrao Kathwate; Rajesh Nivarti Gacche
Journal:  Arch Virol       Date:  2022-01-28       Impact factor: 2.685

Review 5.  Animal Models Used in Hepatitis C Virus Research.

Authors:  Keith A Berggren; Saori Suzuki; Alexander Ploss
Journal:  Int J Mol Sci       Date:  2020-05-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.